Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Biryukov

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Virology|February 14, 2018
Superinfection Exclusion between Two High-Risk Human Papillomavirus Types during a CoinfectionJennifer Biryukov, Craig Meyers
Viruses|August 7, 2015
Papillomavirus Infectious Pathways: A Comparison of SystemsJennifer Biryukov, Craig Meyers
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2014
Replication of human papillomavirus in cultureEric J Ryndock, Jennifer Biryukov, Craig Meyers
Viruses|November 17, 2015
Cleavage of the HPV16 Minor Capsid Protein L2 during Virion Morphogenesis Ablates the Requirement for Cellular Furin during De Novo InfectionLinda Cruz, Jennifer Biryukov, Michael J Conway, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2014
Native human papillomavirus production, quantification, and infectivity analysisJennifer Biryukov, Linda Cruz, Eric J Ryndock, et al.
Virology|September 19, 2016
Comparison of human papillomavirus type 16 replication in tonsil and foreskin epitheliaMohd Israr, Jennifer Biryukov, Eric J Ryndock, et al.
Cancers|September 23, 2020
Anti-Retroviral Protease Inhibitors Regulate Human Papillomavirus 16 Infection of Primary Oral and Cervical EpitheliumSamina Alam, Sreejata Chatterjee, Sa Do Kang, et al.
Viruses|November 11, 2017
Antibody Competition Reveals Surface Location of HPV L2 Minor Capsid Protein Residues 17-36Stephanie M Bywaters, Sarah A Brendle, Kerstin P Tossi, et al.
Viruses|December 20, 2017
Mutations in HPV18 E1^E4 Impact Virus Capsid Assembly, Infectivity Competence, and MaturationJennifer Biryukov, Jocelyn C Myers, Margaret E McLaughlin-Drubin, et al.
Journal of Virology|December 22, 2017
The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune SignalingCindy Chiang, Eva-Katharina Pauli, Jennifer Biryukov, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Virology|February 14, 2018
Superinfection Exclusion between Two High-Risk Human Papillomavirus Types during a CoinfectionJennifer Biryukov, Craig Meyers
Viruses|August 7, 2015
Papillomavirus Infectious Pathways: A Comparison of SystemsJennifer Biryukov, Craig Meyers
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2014
Replication of human papillomavirus in cultureEric J Ryndock, Jennifer Biryukov, Craig Meyers
Viruses|November 17, 2015
Cleavage of the HPV16 Minor Capsid Protein L2 during Virion Morphogenesis Ablates the Requirement for Cellular Furin during De Novo InfectionLinda Cruz, Jennifer Biryukov, Michael J Conway, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2014
Native human papillomavirus production, quantification, and infectivity analysisJennifer Biryukov, Linda Cruz, Eric J Ryndock, et al.
Virology|September 19, 2016
Comparison of human papillomavirus type 16 replication in tonsil and foreskin epitheliaMohd Israr, Jennifer Biryukov, Eric J Ryndock, et al.
Cancers|September 23, 2020
Anti-Retroviral Protease Inhibitors Regulate Human Papillomavirus 16 Infection of Primary Oral and Cervical EpitheliumSamina Alam, Sreejata Chatterjee, Sa Do Kang, et al.
Viruses|November 11, 2017
Antibody Competition Reveals Surface Location of HPV L2 Minor Capsid Protein Residues 17-36Stephanie M Bywaters, Sarah A Brendle, Kerstin P Tossi, et al.
Viruses|December 20, 2017
Mutations in HPV18 E1^E4 Impact Virus Capsid Assembly, Infectivity Competence, and MaturationJennifer Biryukov, Jocelyn C Myers, Margaret E McLaughlin-Drubin, et al.
Journal of Virology|December 22, 2017
The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune SignalingCindy Chiang, Eva-Katharina Pauli, Jennifer Biryukov, et al.
Pageof 2